← Back to Model Beat
Industry·1d ago·all news from November 20, 2026

Novartis CEO: AI Could Cut Drug Development Time by Years

Novartis CEO Vasant Narasimhan stated that integrating artificial intelligence into the pharmaceutical research process could reduce drug development timelines from 12 years to eight. This shift aims to improve success rates for bringing new medications to market by streamlining complex testing and analysis phases.

Covered by 1 source

Related stories

IndustryNvidia Moves On From Huang as Anthropic IPO LoomsNov 17 · 14 sourcesIndustryAnthropic’s Safety Pledges Questioned by Tech Leaders, ScientistsNov 18 · 12 sourcesIndustryChinese tech firms face a double hit as chip shipments stop and overseas cloud access disappearsNov 19 · 6 sourcesIndustryAnthropic prices initial public offeringNov 18 · 5 sources